Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T14:22:08.113Z.
Calculation as of: 2026-09-15T14:22:08.113Z.
Quote observation: 2026-09-15T14:20:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1c8933bd41b5f18e8c28b2ec87f13bea2720d87c8ca1a1551c3665b1c2713349
PEG RATIO
N/A
Vertex Pharmaceuticals Incorporated
Market Cap
$130.12B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $130.12B | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $129.88B | N/A |
| Intuitive Surgical, Inc. (ISRG)vs › | $130.91B | N/A |
| CVS Health Corp. (CVS)vs › | $120.65B | N/A |
| Medtronic plc (MDT)vs › | $119.47B | N/A |
| Danaher Corporation (DHR)vs › | $144.91B | N/A |
| Stryker Corporation (SYK)vs › | $106.75B | N/A |
| McKesson Corporation (MCK)vs › | $104.88B | N/A |
| Pfizer Inc. (PFE)vs › | $156.48B | N/A |
| Sanofi (SNY)vs › | $102.58B | N/A |
PEG Ratio
N/A
P/E Ratio
29.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
